RKRavindra Kamble

Ravindra Kamble

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ravindra Kamble has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigation of magnesium aluminometasilicate (Neusilin US2) based surface solid dispersion of sorafenib tosylate using QbD approach: In vitro and in vivo pharmacokinetic study

    by Bijoy Kumar Panda, Bothiraja Chellampillai, Sharad Ghodke, Ashwin Mali, Ravindra Kamble

    Background and purpose: Sorafenib tosylate (SFN), a potent multikinase inhibitor, is used for the treatment of various cancers. However, it shows limited therapeutic applications due to its poor biopharmaceutical properties. The aim of the present investigation is to develop surface solid dispersion (SSD) of SFN using adsorbent to improve its solubility, bioavailability and therapeutic efficacy. Experimental approach: The SFN-SSD was prepared by modified solvent evaporation technique using Neusilin US2 (magnesium alumino­metasilicate) as an adsorbent and sodium dodecyl sulphate as a surfactant. SFN-SSD was optimized by adopting the design of experiment (DOE) using 32 factorial designs and characterized in terms of in-vitro and in-vivo efficacy. Key results: The obtained SFN-SSD showed more than 20-fold improvement in SFN solubility. The FTIR depicted hydrogen bonding between SFN and Neusilin. Further, PXRD and DSC indicated the molecular dispersion of SFN to be amorphous. SFN-SSD and SFN immediate release tablets reflected cumulative release of 97.13 and 29.93 % in 1 h. The pharmacokinetics study of SFN-SSD showed 2 and 6.5-fold improvement in maximum concentration (Cmax,) and area under the curve (AUC0-t) as compared to pure SFN due to faster drug release at the absorption site. Conclusion: The study concluded that the SSD could be a scalable formulation approach and more industry-friendly technology to improve the biopharmaceutical properties of SFN.


  • Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small cell lung cancer

    by Khushboo Patel, Chellampillai Bothiraja, Ashwin Mali, Ravindra Kamble

    The present hypothesis was to identify the potential of sorafenib tosylate (ST) loaded liposomal dry powder inhaler (ST-LDPI) for targeting non-small cell lung cancer (NSCLC). ST-LDPI was obtained by spray drying the ST loaded liposomes, evaluated for physicochemical properties and in vitro lung deposition by Andersen Cascade Impactor (ACI). Optimized liposomal formulation showed the particle size, zeta potential, encapsulation efficiency and drug content of 111.15 ± 1.03 nm, −29.87 ± 0.56 mV, 93.13 ± 1.11% and 84.47 ± 1.28%, respectively. Furthermore, ST-LDPI exhibited low density and good flowability. FESEM confirmed the spherical nature of particles with mean size of 3.15 ± 0.51 μm. The DSC and FTIR spectra revealed complete encapsulation of ST. Further, the PXRD showed reduced crystallinity ST. In vitro deposition demonstrated the fine particle fraction of 83.7 ± 0.09%, recovery of 95.43 ± 0.03%, mean mass aerodynamic diameter 3.15 ± 0.2 µm, geometric standard deviation 1.78 ± 0.15 µm and 85 ± 0.1% dispersibility. The In vitro drug release revealed biphasic release pattern, burst release in the first 6 h followed by sustained release up to 72 h. Hence this novel approach could be a targeted delivery of ST to the NSCLC treatment.


  • D-α-Tocopherol polyethylene glycol succinate and stearoylmacrogol glycerides biomaterial based nanostructured mixed micelles as nose-to-brain targeting drug delivery system

    by C. Bothiraja, Kartiki Dhage, Ravindra Kamble

    Olanzapine (OLA), a first atypical antipsychotic moleculethat experiences low brain permeability because of efflux by P-glycoproteins (Pgp) in the brain and extensive hepatic first-pass metabolism. The present investigation intended to design OLA-loaded mixed micelles (MM) and study their nose-to-brain targeting capability. OLA-MM was prepared by a mixture of d-α-tocopheryl polyethylene glycol 1000 succinate and gelucire®44/14 (stearoylmacrogol glycerides) (OLA-TPGL-MM) using the solvent evaporation technique. OLA-TPGL-MM was studied for various physiochemical properties, in-vitro release, ex-vivodrug permeation and in-vivo pharmacokinetic potential in male Wister rats as compared to OLA alone. Developed OLA-TPGL-MM showed particle size, negative zeta potential and entrapment efficiency of 125 nm, −5.97 mV and > 83%, respectively. OLA-TPGL-MM showed 2.12 and 1.85-fold improvement in in-vitro and ex-vivo OLA release and permeation. Substantially higher values for intranasal (i.n) OLA-TPGL-MM in drug targeting efficiency (265.36%), drug targeting index (1.82) and direct transport percentage (64.36%) indicating the potential of non-invasive OLA-loaded MM nose-to-brain targeting delivery system. TheTPGS and gelucire®44/14 based MM has a great potential for the safe and effective delivery of antipsychotic molecules in the treatment of CNS disorders. GRAPHICAL ABSTRACT


  • Albendazole Electrospun Nanofiber Films: In-vitro and Ex-vivo Assessment

    by R. N. Kamble, R. V. Mehtre, P. P. Mehta, P. Nangare, S. S. Patil


  • Open Access

    Electrospray technique for cocrystallization of phytomolecules

    by Sharvil Patil, Khushbu Chaudhari, Ravindra Kamble

    Poor aqueous solubility of most of the phytomolecules has restricted their vital biological use. Cocrystal approach can be one of the remedies for the problem. The present work was carried out with an objective to screen the potential of electrospray technique towards cocrystallization of quercetin (QUE). QUE was cocrystallized with caffeine (CAF) and nicotinamide (NIC) as coformers. Saturated methanolic solutions of QUE with either of the coformers (CAF and NIC) in 1:1 ratio were electrosprayed at 40 °C. The technique was successfully used for cocrystallization of QUE with CAF and NIC separately as revealed by Powder X-ray Diffraction, Differential scanning calorimetry and Fourier transform infrared spectroscopy studies. Additionally, the results of saturation solubility study suggested 14 and 11 folds increase in solubility of QUE upon its cocrystallization with CAF and NIC respectively. Herein we propose a new technique for cocrystallization and in turn resolving solubility issues of phytomolecules which can be an alternative to the existing cocrystallisation techniques


  • Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation

    by Ravindra N. Kamble, Piyush P. Mehta, Ajay Kumar

    Self-emulsifying drug delivery system (SEDDS) is the isotropic and thermodynamically stable mixture of oil, surfactant, co-solvent/surfactant, and drug. It emulsifies spontaneously when introduced into an aqueous phase under a mild agitation. The current study was aimed to prepare SNEDDS to augment solubility, release rate, and oral bioavailability of BCS class II drug, efavirenz (EFV). A series of oil, surfactant, and co-surfactant was screened out by a ternary phase diagram to locate a better homogenous mixture. The prepared SNEDDS was evaluated regarding its appearance, mean droplet size, phase separation, in vitro drug release, and oral bioavailability. Among the screened oil, surfactant, and co-surfactant, Labrafil M 2125 CS, Tween 80, and Transcutol®P mixture exhibited superior solubilizing capacity, respectively. Optimized SNEDDS exhibits 98.39% drug release. SNEDDS dissolution behavior was attributed to oil/surfactant ratios and properties of the surfactant phase. It also demonstrates threefold increments in the area under curve (AUC) in comparison to neat EFV. Furthermore, the optimized SNEDDS does not show any vitrification during its 3-month storage. In the present study, better performance of SNEDDS is explained by various factors like (i) improved surface area of droplets, (ii) superior solubilization potential for hydrophobic drugs due to Labrafil M 2125 CS, and (iii) result of surfactant on mucosal permeability. This study demonstrated that SNEDDS may be an alternative approach for the poorly soluble drugs to improve their solubility and oral bioavailability.


  • Open Access

    Effect of variables on Naproxen Agglomerates Engineered by Melt Sonocrystallization

    by Ravindra Kamble, Priyanka Nangare, Lalit Garge

    The study deals with melt sono crystallization (MSC) technique for the preparation of agglomerates of naproxen. Purpose is to improve the solubility and compressional properties of naproxen. In the present study naproxen agglomerates prepared by MSC and melt solidification technique (MST) and the effect of variables like time of sonic energy, amplitude and temperature of the deionized water on agglomerates were compared. The technique involves application of ultrasonic energy to the soft viscous

  • PHYTOCHEMICAL AND PHARMACOLOGICAL ASPECTS OF SANDALWOOD

    by P. P Mehta, R. M Shah, V. M Shinde, R. N Kamble, K. R. Mahadik

    Sandalwood (Santalum album L.) is one of the most famous and widely used plants in perfumery and cosmetics. Apart from perfumery and cosmetics uses, sandalwood also has a wide range of pharmacological activities and the plant can be considered as one of the important medicinal plants. Since last two decades, this plant has been studied extensively but still there is lot of scope to exploit full potential of uses of sandalwood for mankind. Various studies report that of effects sandalwood oil is responsible for various effects ranging from antibacterial to anticancer. It also shows prominent activity in various skin diseases. There are few toxicological studies on sandalwood. It is necessary to summaries all activities reported about this plant. This review consolidates different reported activities of sandalwood plant as well as its oil.